EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Persistence of a Frameshifting Deletion in SARS-CoV-2 ORF7a for the Duration of a Major Outbreak

Charles S P Foster iD, Rowena A Bull iD, Nicodemus Tedla, Fernando Santiago, David Agapiou, Anurag Adhikari, Gregory J Walker iD, Lok Bahadur Shrestha iD, Sebastiaan J Van Hal, Ki Wook Kim iD, William D Rawlinson iD

Viruses · 2023

DOI: 10.3390/v15020522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Charles S P Foster und 10 weiteren Autor:innen. Beteiligte Einrichtung: Serology and Virology Division (SAViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP), Medical Research Future Fund (MRFF), National Health and Medical Research Council (NHMRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Australia experienced widespread COVID-19 outbreaks from infection with the SARS-CoV-2 Delta variant between June 2021 and February 2022. A 17-nucleotide frameshift-inducing deletion in ORF7a rapidly became represented at the consensus level (Delta-ORF7aΔ17del) in most Australian outbreak cases. Studies from early in the COVID-19 pandemic suggest that frameshift-inducing deletions in ORF7a do not persist for long in the population; therefore, Delta-ORF7aΔ17del genomes should have disappeared early in the Australian outbreak. In this study, we conducted a retrospective analysis of global Delta genomes to characterise the dynamics of Delta-ORF7aΔ17del over time, determined the frequency of all ORF7a deletions worldwide, and compared global trends with those of the Australian Delta outbreak. We downloaded all GISAID clade GK Delta genomes and scanned them for deletions in ORF7a. For each deletion we identified, we characterised its frequency, the number of countries it was found in, and how long it persisted. Of the 4,018,216 Delta genomes identified globally, 134,751 (~3.35%) possessed an ORF7a deletion, and ORF7aΔ17del was the most common. ORF7aΔ17del was the sole deletion in 28,014 genomes, of which 27,912 (~99.6%) originated from the Australian outbreak. During the outbreak, ~87% of genomes were Delta-ORF7aΔ17del, and genomes with this deletion were sampled until the outbreak’s end. These data demonstrate that, contrary to suggestions early in the COVID-19 pandemic, genomes with frameshifting deletions in ORF7a can persist over long time periods. We suggest that the proliferation of Delta-ORF7aΔ17del genomes was likely a chance founder effect. Nonetheless, the frequency of ORF7a deletions in SARS-CoV-2 genomes worldwide suggests they might have some benefit for virus transmission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansAustraliaDisease OutbreaksPandemicsRetrospective StudiesViral Proteins

Stichwörter der Autor:innen

ORF7aSARS-CoV-2indeloutbreak

Substanzen

ORF7a protein, SARS-CoV-2Viral Proteins

Autor:innen und Institutionen

  • Serology and Virology Division (SAViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
  • School of Biomedical Sciences, Faculty of Medicine & Health, University of New South Wales, Sydney, NSW 2052, Australia.
  • The Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, NSW 2052, Australia.
  • Department of Infection and Immunology, Kathmandu Research Institute for Biological Sciences, Lalitpur 44700, Province Bagmati, Nepal.
  • Department of Infectious Diseases and Microbiology, NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia.
  • Central Clinical School, University of Sydney, Sydney, NSW 2006, Australia.

ORCID-Profile: Charles S P Foster, Rowena A Bull, Gregory J Walker, Lok Bahadur Shrestha, Ki Wook Kim, William D Rawlinson

Förderung

  • Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP)
  • Medical Research Future Fund (MRFF)
  • National Health and Medical Research Council (NHMRC)

Zitieren

APA

Foster, C. S. P., Bull, R. A., Tedla, N., Santiago, F., Agapiou, D., Adhikari, A., Walker, G. J., Shrestha, L. B., Van Hal, S. J., Kim, K. W., & Rawlinson, W. D. (2023). Persistence of a Frameshifting Deletion in SARS-CoV-2 ORF7a for the Duration of a Major Outbreak. Viruses. https://doi.org/10.3390/v15020522

Vancouver

Foster CSP, Bull RA, Tedla N, Santiago F, Agapiou D, Adhikari A, et al. Persistence of a Frameshifting Deletion in SARS-CoV-2 ORF7a for the Duration of a Major Outbreak. Viruses. 2023. doi:10.3390/v15020522

BibTeX
@article{Foster2023,
  author = {Foster, Charles S P and Bull, Rowena A and Tedla, Nicodemus and Santiago, Fernando and Agapiou, David and Adhikari, Anurag and Walker, Gregory J and Shrestha, Lok Bahadur and Van Hal, Sebastiaan J and Kim, Ki Wook and Rawlinson, William D},
  title = {Persistence of a Frameshifting Deletion in SARS-CoV-2 ORF7a for the Duration of a Major Outbreak},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15020522}
}
Kostenlos starten →